A Multicomponent Intervention for Patients With Lumbosacral Radiculopathy: Move-MORE

Inclusion Criteria: * ● Adults age 18-65 years at the time of enrollment * Ability to stand for 10 minutes * Presence of lumbosacral radicular pain within the past week that extends below the knee (i.e., pain radiating from the low back into the leg in a nerve root distribution) with or without accompanying low back pain, of at least 12 weeks' duration, AND * Tampa Scale of Kinesiophobia score ≥ 23 * At least one positive physical examination finding consistent with lumbosacral radiculopathy, including at least one of the following: * Positive straight leg raise test (eliciting radicular pain below the knee at ≤70 degrees of elevation); * Positive Valsalva maneuver (eliciting radiculcar pain below the knee); * Positive slump test; * Neurological deficit in a lumbar nerve root distribution, including at least one of the following: * Dermatomal sensory loss, * Myotomal weakness, or * Reduced or absent deep tendon reflexes (e.g., patellar or Achilles reflex) corresponding to the affected nerve root. * Daily access to the internet via cell phone, tablet, or computer * Willing to engage with Move-MORE 4-5 times per week on your own * Willing to attend a two-hour-long virtual Zoom meeting once per week for eight weeks * Willing to attend two in-person study visits and a follow-up visit * Willing to complete 18 questionnaires pertaining to your pain symptoms, quality of life, psychosocial experiences, and your experiences in the trial * Willing to wear an actigraphy device all day, every day, and while sleeping, for the duration of study participation and willing to keep it charged * Willing to respond to a daily online survey for the duration of study participation * Able to speak, read, and understand the English language * Able to provide written informed consent * Moderately motivated to participate as reported on a numeric rating scale (≥ 4/10) Exclusion Criteria: * ● Participants will be excluded if they have clinical signs or symptoms of lumbosacral radiculopathy with progressive neurologic deficits (loss of motor or sensory function) or intolerable pain. * Participants with lumbosacral radiculopathy with progressive neurologic deficits will be referred for immediate medical attention, and are not eligible for participation in this study. ● Participants will be excluded if they have clinical signs or symptoms suggestive of cauda equina syndrome, including any of the following: * New-onset urinary retention or overflow incontinence not attributable to other known causes; * Fecal incontinence; * New onset of saddle anesthesia (loss of sensation in the buttocks, perineum, and inner thighs); * Severe or progressive bilateral lower extremity weakness; * Participants with suspected cauda equina syndrome will be referred for immediate medical attention, and are not eligible for participation in this study. * Presence of moderate to severe foot drop, defined as noticeable weakness in ankle dorsiflexion that interferes with walking or requires the use of an assistive device (e.g., ankle-foot orthosis). Participants with suspected or worsening foot drop will be referred for further evaluation and are not eligible for study participation. * Current use of a spinal cord stimulator * Have received epidural steroid injection in the prior 3 months * Have received a surgical intervention for low back pain or lumbosacral radiculopathy in the previous 6 months * Current active mindfulness meditation practice 1 time/week or more, and/or history of formal training in mindfulness/meditation practice * Concurrent diagnosis of cancer * Current unmanaged or uncontrolled mental illness known to cause psychosis: schizophrenia, schizotypal disorders, bipolar I disorder with psychosis, major depressive disorder with psychosis * Diagnosis of Borderline Personality Disorder or score \>6 on the McLean Screening Instrument for Borderline Personality Disorder * Initiation of or changes to an exercise regimen within 2 weeks prior to screening and/or enrollment * Major medical or surgical event requiring hospitalization (for any reason other than a minor scheduled medical procedure) within 3 months prior to screening; or, scheduled or will be scheduled to occur within the 20 weeks (i.e., five months) after enrollment * Currently participating in another interventional research study or participated in another interventional study within 2 weeks prior to screening * Any reason the Clinical Investigator or Principal Investigator believes confers increased risk to the potential participant, if they were to enroll in the study